A Plea for Neutral Comparison Studies in Computational Sciences by Boulesteix, Anne-Laure & Eugster, Manuel J. A.
ar
X
iv
:1
20
8.
26
51
v1
  [
sta
t.C
O]
  1
3 A
ug
 20
12
A plea for neutral comparison studies
in computational sciences
Anne-Laure Boulesteix1 and Manuel J. A. Eugster2
October 29, 2018
1Department of Medical Informatics, Biometry and Epidemiology, University of Munich,
Marchioninistr. 15, 81377 Munich, Germany.
2Department of Statistics, University of Munich, Ludwigstr. 33, 80539 Munich, Germany.
Abstract
In a context where most published articles are devoted to the development of “new meth-
ods”, comparison studies are generally appreciated by readers but surprisingly given poor
consideration by many scientific journals. This letter stresses the importance of neutral
comparison studies for the objective evaluation of existing methods and the establishment
of standards by drawing parallels with clinical research.
1 Introduction
The main goal of methodological research in computational sciences (including, e.g.
bioinformatics, machine learning, or computational statistics) is the development of new
methods. By development of new methods, we mean that the researchers suggest new
procedures for analyzing data sets. The new procedure should be applicable to specific
substantive research questions, but these substantive research questions (often) are not the
primary center of interest of the methodological researcher. A methodological researcher
develops new methods, in contrast to substantive researchers who apply the methods de-
veloped by others, e.g. to their e.g. genetic or transcriptomic data. New methods are
expected to “make the world better” by, roughly speaking, making the results of statistical
analyses closer to the truth. Surprisingly, comparison studies and reviews investigating
the closeness to the truth are often considered as less exciting and less useful by many
researchers or by most journal editors, and excluded from the journals’ scopes.
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This is in strong contrast to clinical research. The ultimate goal in clinical research
is to “make the world better” by somehow improving the health outcome of patients (or
reducing the cost while maintaining the same outcome), e.g. through a specific drug, ther-
apy or prevention strategy. Roughly speaking, the clinical analogue of a computational
article suggesting a “new method” would be an article suggesting a new intervention for
improving health outcome. Yet, most published medical papers do not directly suggest
such a new measure. Many other types of clinical research projects are conducted, for
instance large validation studies, phase IV clinical trials, or meta-analyses. Of course,
crucial differences between computational science research and medical research make
comparisons only partially pertinent. Research on algorithms and methods does not fol-
low the same rules as research involving human beings with direct potentially vital conse-
quences. The development of a new drug or new prevention strategy essentially requires
more time, money, coordination and caution than the development of a new statistical
method. Some principles, however, hold for both worlds. If we focus on the problem of
comparison studies considered in this paper, the question is “can we imagine a world in
which clinical journals accept to publish only underpowered phase I or II clinical trials
evaluating new therapies but no phase III or IV trials?” The answer is of course no. In data
analysis journals, however, the equivalent of phase III and IV trials, i.e. well-conducted
comparison studies in our metaphor, are often considered as not deserving publication.
We claim that comparison studies in computational sciences may however be neces-
sary to ensure that previously proposed methods work as expected in various situations
and that emerging “standard practice rules” adopted by substantive researchers or sta-
tistical consultants are the result of well-designed studies performed by computational
science experts. The community tends to establish standards and guidelines as time goes
by. In an ideal world, these standards are the results of well-done comparative studies and
consensus from independent teams. However, other factors might contribute to promote a
particular method, including the reputation of the authors or the impact factor of the jour-
nals the method was published in. From the point of view of applicants (say, biologists),
further criteria include the availability of well-documented and user-friendly implemen-
tations of the method or an application of this method in one of the few leading scientific
journals that other scientists tend to imitate. These criteria may seem natural. After all, a
method published by a renown author in an excellent journal is more likely to work well
than a method published by an unknown author in a low-ranking journal. Availability of
good software is of course a crucial advantage for applicants who would not be able or
would not have time to implement any of the methods themselves. And a method that
worked well in a previous well-published study is perhaps more likely to also work well
in future studies than another method.
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It is unclear, however, whether standard practice rules should be established solely on
such “subjective” criteria. Would it not be better to give more importance to compari-
son studies? One may of course argue that comparison studies can be performed within
original articles presenting new methods. Indeed, in practice new methods are usually
compared to a few existing methods in order to establish their superiority. Such com-
parison studies are extremely important for illustrative purposes, i.e. to demonstrate that
the developed method is applicable in practice and yields acceptable results, but should
strictly speaking not be considered as comparison studies because they are often substan-
tially biased and thus not “neutral”.
For example, in the context of clinical outcome prediction or diagnosis based on high-
dimensional “omics data” (such as, e.g. microarray gene expression data), hundreds of
articles presenting new supervised classification algorithms have been published in the
bioinformatics, statistics and machine learning literature. Almost all of them claim that
the new method “performs better” than existing methods. Most often these claims are
based on small real data studies including a few exemplary data sets. The fact that for
twelve years hundreds of authors have been claiming that their new method for classifica-
tion using microarray data performs better than existing ones suggests that something goes
wrong in the comparison studies performed in these articles. Similar discussions can be
found in other fields of application of machine learning and computational statistics [e.g.,
9]. What goes wrong? How should a proper comparison study look like? Is it possible
to perform such comparison studies in the context of an original article presenting a new
method?
2 Over-optimism and the need for neutral comparison
studies
Comparison studies included in original research articles presenting new methods are
often over-optimistic with respect to the superiority of the new method. Some reasons
for over-optimism have been empirically assessed and discussed in the context of super-
vised classification using high-dimensional molecular data [1, 6]. The first and perhaps
most obvious reason for over-optimism is that researchers sometimes “randomly search”
for a specific data set such that their new method works better than existing approaches,
yielding a so-called “data set bias” [10]. A second source of over-optimism, which is
related to the optimal choice of the data set mentioned above, is the optimal choice of
a particular setting in which the superiority of the new algorithm is more pronounced.
For example, researchers could report the results obtained after a particular feature fil-
tering which favors the new algorithm compared to existing benchmark approaches. The
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third and probably most subtle problem is that researchers often tend to optimize their
new algorithms to the data sets they consider during the development phase [1, 6]. This
mechanism essentially affects all research fields related to data analysis such as statis-
tics, machine learning, or bioinformatics. Indeed, the trial-and-error process constitutes
an important component of data analysis research. As most inventive ideas have to be
improved sequentially before reaching an acceptable maturity, the development of a new
method is per se an unpredictable search process. The problem is that this search pro-
cess leads to an artificial optimization of the method’s characteristics to the considered
data sets. Hence, the superiority of the novel method over an existing method (as mea-
sured, e.g. through the difference between the cross-validation error rates) is sometimes
considerably overestimated.
Other reasons are of technical nature and related to the ability of the researchers to
use the compared methods properly. For example, if an implementation problem occurs
with the competing approaches and slightly worsens their results, researchers often tend
to spontaneously accept these inferior results. Conversely, they would probably obsti-
nately look for the programming error if such problems occur with their new algorithm.
In the same vein, they may unintentionally set the parameters of competing methods to
sub-optimal values, or choose a variant of the method that is known by experts to be sub-
optimal. They may also select competing methods in a sub-optimal way, i.e. consciously
or sub-consciously exclude the best methods from the comparison. Beyond the prob-
lems of technical expertise and optimization bias, interpretation and representation issues
might also affect the final conclusions of a comparison study. Given the same quantitative
outputs, the impression of the reader can be affected, e.g., by the choice of the vocabulary
in the results section, by graphical representation, or by the choice of the main quantitative
criterion used to compare the methods.
For all these reasons, most comparison studies published in the literature as part of an
original paper are substantially biased. These problems stress the importance of “neutral
comparison studies” that we define as follows:
A. The main focus of the article is the comparison itself. It implies that the primary
goal of the article is not to introduce a new promising method.
B. The authors should be reasonably “neutral”. For example, an author who has pub-
lished an article on a new method six months before is likely to be less neutral
than an author who has often used several of the considered methods for statis-
tical consulting and, say, previously investigated three of them more precisely in
methodological articles.
C. The evaluation criteria, methods, and data sets should be chosen in a rational way,
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see Section 4 for a more extensive discussion of this problem.
Note that the comparison between the competing methods is essentially not affected
by the bias discussed in the introduction. Hence, one idea could be to extract neutral com-
parisons from comparison studies included in original articles presenting new methods—
by considering the competing methods only. However, one should keep in mind that these
methods probably have not been given as much attention as in the case of a real neutral
comparison study that does not involve any new method. This relative lack of attention
possibly leads the underestimation of their performance.
To come to the point, in an original article on a new method, the focus is on the new
method, and that is where the authors generally spend most of their energy. Consequently,
comparisons between competing methods should not be over-interpreted because they
may be of sub-optimal quality. On this account we make a (passionate) plea for neutral
comparison studies in computational sciences.
3 Tidy neutral comparison studies
In the same way clinical research and clinical studies have to be well planned and exe-
cuted (following strict guidelines), comparison studies should also follow a well-defined
study design. They should be based on a sound theoretical framework, appropriate anal-
ysis methods, and carefully selected components. There is a variety of literature on the
design and analysis of comparison studies available—we propagate, for example, Hothorn
et al. [5] as a theoretical framework and Eugster et al. [4] as its practical implementation.
However, regardless of the concrete framework, general considerations on the individual
components—evaluation criteria, methods and method parameters, and data sets—can be
made.
• Choice of evaluation criteria: In the case of supervised learning algorithms, simple
evaluation criteria are, e.g., the error rate or preferably the area under curve that
is based on the predicted class probabilities. Such criteria are natural and objec-
tive. However, many other criteria have an impact on the usefulness of a method in
practice for applications. From a pedagogical point of view, one should not forget
that the method is destined to be used by experts or non-expert users. Therefore, all
other things being equal, simplicity of a method constitutes an important advantage,
similarly to the clinical context where the simplicity of a therapy protocol should be
seen as a major advantage. From a technical point of view, particular attention may
be devoted to computational aspects such as computation time and storage require-
ments (similarly to the costs in the clinical context), the influence on initial values
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in an iterative algorithm, or more generally the dependence on a random generator
(similarly to the robustness of the therapy’s effect against e.g. technical problems
or human errors).
• Choice of methods and method parameters: The choice of methods is a very subjec-
tive one. At any rate, the concrete choice should be clearly motivated and personal
preferences and similar influences should be clearly acknowledged. Researchers
are inevitably conducted by personal preferences, past experiences and own techni-
cal competence. However, the choice should also be guided by objective arguments.
Possible criteria are i) the popularity of the methods in practice (for instance: re-
strict to methods that have been used in at least three concrete studies), ii) results
available from the literature (e.g. from a previous comparison study) to pre-filter
good candidates, or iii) specific pre-defined criteria specifying the nature of the
method, for example “only statistical regression-based methods”. None of these
criteria should be considered as mandatory for a neutral comparison study. But we
claim that, the set of criteria being defined, the methods should be more or less
randomly sampled within the range of available methods.
As far as method parameters like hyperparameters are concerned, they should be
chosen based on “standard practice rules”.
• Choice of data sets: Researchers performing comparison studies also choose data
sets. Considering the high variability of relative performance across data sets, a
comparison study based on different data sets (all other things being equal) may
obviously yield different results. Variability arises both because error estimation
with standard resampling-based estimators is highly variable for a given underlying
joint distribution of predictors and response [3] and because different data sets also
have different underlying distributions. Therefore, it is important to make an “as
representative as possible” selection of data sets to cover the domain of interest.
At best, the data sets are chosen from a set of data sets representing the domain of
interest using standard sampling methodology.
In summary, many choices have to be met when performing a comparison study, for
example, in the case of supervised learning with high-dimensional data: the included
methods (e.g. penalized regression, tree ensembles, support vector machines, partial least
squares dimension reduction, etc), the considered variants (which kernel for SVM, which
fitting algorithm for penalized regression, which optimality criterion for PLS, which split-
ting criterion for tree ensembles, etc), the data domain (which type of data sets), the pa-
rameter tuning procedure (which resampling scheme, which candidate values). With this
in mind, it is clear that the topic of interest cannot be handled completely by a single
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comparison study. Different comparison studies with similar scope may yield different
conclusions. This can be seen as a limitation of each single comparison study – or as
an argument to perform more such comparison studies. Going one step further in the
comparison with clinical research, one could also imagine a concept of meta-analysis for
comparison studies in computational sciences. In the clinical context, meta-analyses pro-
vide a synthesis over different populations, different variants of the investigated therapies,
different technical conditions, different medical teams, etc. Similarly, meta-analyses for
computational studies in computational sciences would provide syntheses over different
data domains, different variants of the considered methods, different software environ-
ments, different teams with their own areas of expertise, etc.
4 Negative results
Comparison studies can be a good vehicle for negative research findings. Publication bi-
ases and the necessity to ”accentuate the negative” [8] are well-documented in the context
of medical and pharmaceutical research. In applied statistics and data analysis research,
however, this issue receives very poor attention [1], even if the publication of negative
results may be extremely useful in many cases.
The systematic exclusion of negative results from publication might in some cases
be misleading. For example, imagine that ten teams around the world working on the
same specific research question have a similar promising idea that in fact does not work
properly for any reason. Eight of the ten teams obtain disappointing results. The ninth
team sees a false positive in the sense that they observe significant superiority of the new
promising method over existing approaches although it is in fact not better. The tenth team
optimizes the method’s characteristics [6] and thus also observes significant superiority.
The two latter teams report the superiority of the promising idea in their papers, while the
eight other studies with negative results remain unpublished: a typical case of publication
bias. This scenario is certainly caricatural, but similar things are likely to happen in
practice although in a milder form. Note that it is very difficult to give concrete examples
at this stage, since such stories essentially remain unpublished.
Nevertheless, the publication of negative results might entail substantial problems.
Most researchers (including ourselves!) probably have more ideas that turn out to be dis-
appointing than ideas that work fine. Try-and-error is an essential component of research.
It would thus be impossible (and uninteresting anyway) to publish all negative results.
But then, what was promising and what was not promising? What is likely to interest
readers and what was just a bad idea that nobody else would have thought of? Obviously
this decision that would have to be taken by reviewers and editors is a subjective one.
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Assessing whether a new method with negative results deserves publication in a separate
paper is anything but trivial. With this in mind, we believe that the publication of negative
findings within large well-designed comparison studies would be a sensible compromise
in order to diffuse negative findings without congesting the literature with negative papers.
Journals would not have to fear for their impact, since good comparison studies are
usually highly accessed and cited. Authors would not be urged to make something out
of their promising idea on which they have spent a lot of time: a large comparison study
would be an alternative to publish important results and share their vast experience on the
topic without fishing for significance. And "fishing for significance" would lose part of
its attractiveness. Most importantly, readers would be informed about important research
activities they would not have heard of otherwise.
Note that “standard practice rules” in computational sciences (e.g., regarding the
choice of method parameters) are often implicitly the result of comparison studies. For
instance, a “standard parameter value” becomes standard because it yields better results
than another value. In other words, negative results are often hidden behind standard
practice rules - most of them remaining unpublished. Our point is that this process could
be made more transparent and more informative for the readers if these negative results
were published within extensive comparison studies.
Drawing the comparison with clinical research from the introduction even further,
we also think that it may be interesting to publish articles on “pitfalls”. By “pitfall” we
mean the inconveniences of a data analysis method such as, e.g., a non-negligible bias,
a particularly high variability, or non-convergence of an algorithm in specific cases that
may lead to misleading results. By “negative result” we mean a disappointing result of
a new method that had been considered as promising problem solver for a specific case.
In computational literature such research results are often hidden in the middle of articles
that are actually devoted to something else. This is in contrast to clinical research, where
pitfalls of existing methods (e.g. an adverse effect of a drug) may be the main object of an
article, even if no alternative solution is proposed (for example in form of an alternative
drug).
5 Limitations
Neutral comparison studies are in our opinion crucial to make the establishment of stan-
dards more objective and to give a chance to methods that are at first view unspectacu-
lar and would otherwise be pigeonholed. However, comparison studies and their impact
should not be over-interpreted. Firstly, one should not forget that no method is expected to
work well with all data sets (the well-known “no free lunch theorem”). Hence, a method
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that scores well in many comparison studies may do poorly in a specific data set. Compar-
ison studies are not expected to yield an absolute truth applicable to all situations. They
are solely useful to determine general trends that may be useful to the community to select
a set of standard methods that often perform well.
Secondly, comparison studies are essentially limited because they rely on the specific
and sometimes arbitrary choices regarding the study design: the choice of simplifying
evaluation criteria that probably do not reflect the complexity of concrete data analysis
situations, the choice of method parameters that may substantially impact the relative per-
formance of the considered methods, and last but not least the choice of specific example
data sets.
Thirdly, comparison studies are often underpowered in the sense that the number of
included data sets is insufficient considering the high variability of performance across
data sets. With a few exceptions (see [2] for a comparison of machine learning algorithms
based on 65 gene expression data sets), comparison studies often include up to 10-15
data sets, which is probably not enough. This issue may be further investigated in future
research.
Fourthly, comparison studies essentially ignore the substantive context of the data
sets they consider. Data sets are sometimes preprocessed without much knowledge of
the signification of the variables. All methods are applied in the same standardized way
to all data sets. The analysis is thus intentionally over-simplified. An important aspect
of the data analysis approach is neglected, which does not reflect the complexity and
subtleties of the data analyst’s work [7]. A method that does not work well if applied
in a standard way without knowledge of the substantive context might perform better in
concrete situations, hence reducing the relevance of comparison studies.
6 Conclusion
Neutral comparison studies are often considered as less exciting than project on new meth-
ods by both researchers and journal editors – but not by readers. They can neither be
expected to always give the best answer to the question “which method should I use to
analyze my data set” nor reflect a real data analysis approach that takes the substantive
context into account. However, we believe that they may play a crucial role to make the
evaluation of existing methods more rational and to establish standards on a scientific ba-
sis. They certainly deserve more consideration than is currently the case in the literature.
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